A. A. Spiridonov
A. A. Spiridonov has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Gartung
MedicBook LLC
2 shared publications - A. E. Uranov
MedicBook LLC
2 shared publications - A. M. Shangina
Chazov National Medical Research Center of Cardiology
2 shared publications - Filipp Paleev
National Medical Research Center of Cardiology, 3-Ya Cherepkovskaya Ulitsa, 15A, 121552 Moscow, Russian Federation
2 shared publications - Igor L. Mikheenko
Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск
2 shared publications - Irina I. Shestova
Tula Regional Clinical Cardiology Dispensary
2 shared publications
Latest Publications
- Open Access
- 17 August 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (7) , 4462
Impact of a clinical decision support system on adherence to clinical guidelines in the management of patients with heart failure (SPHERA-HF study)
Aim . To assess the impact of a clinical decision support system (CDSS) aimed at increasing physician compliance with clinical guidelines on heart failure (HF) in real-world practice in order to improve the effectiveness of managing this category of patients and clinical outcomes in pilot Russian regions. Material and methods . As part of the retrospective multicenter study SPHERA-HF, data of electronic health records from 49 medical facilities in three Russia regions were analyzed. The study participants were divided into inpatient and outpatient cohorts. The main inclusion criterion was a history of HF diagnosis. The features of patient management in real-world practice were studied before and after the implementation of the CDSS. Results. The study included 66166 patients. After CDSS imple neprilysin inhibitors in patients with HF with reduced ejection fraction increased in the in-hospital cohort from 32,9% to 52,3% (pConclusion. The study results indicate a positive impact of CDSS introduction on managing patients with HF.
- 17 August 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (7) , 4462
Open AccessImpact of a clinical decision support system on adherence to clinical guidelines in the management of patients with heart failure (SPHERA-HF study)
Aim . To assess the impact of a clinical decision support system (CDSS) aimed at increasing physician compliance with clinical guidelines on heart failure (HF) in real-world practice in order to improve the effectiveness of managing this category of patients and clinical outcomes in pilot Russian regions. Material and methods . As part of the retrospective multicenter study SPHERA-HF, data of electronic health records from 49 medical facilities in three Russia regions were analyzed. The study participants were divided into inpatient and outpatient cohorts. The main inclusion criterion was a history of HF diagnosis. The features of patient management in real-world practice were studied before and after the implementation of the CDSS. Results. The study included 66166 patients. After CDSS imple neprilysin inhibitors in patients with HF with reduced ejection fraction increased in the in-hospital cohort from 32,9% to 52,3% (pConclusion. The study results indicate a positive impact of CDSS introduction on managing patients with HF.
- Open Access
- 28 November 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (6) , 625-636
The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)
Aim. To assess the effectiveness of clinical decision support system (CDSS) implementation strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients hospitalized for acute cardiovascular events (CVEs), in patients with coronary artery disease (CAD) or dyslipidemia.Material and methods. A non-interventional, retrospective, multicentre study assessing the impact of a CDSS with automatic electronic medical record (EMR) data processing on adherence to guidelines in patients at risk of cardiovascular diseases (SuccESS) was performed. The study included two cohorts of patients from healthcare facilities in three regions of Russia. The main cohort consisted of patients hospitalized for acute CVEs, with 12,227 patients included in the first follow-up period and 11,364 patients included in the second follow-up period. The additional cohort consisted of patients with stable CAD or dyslipidemia, with 54 469 patients included in the first follow-up period and 94,616 patients included in the second follow-up period. The study assessed follow-up findings in real-world clinical practice before and after the CDSS was implemented (first and second follow-up periods, respectively). The median duration of follow-up in the main cohort was >158 days in the first follow-up period and >227 days in the second follow-up period.Results. In the second follow-up period the proportion of patients with available data on LDL-C control in the EMR increased from 12.3% to 18.8% (here and further — relative change: +52.3%, pConclusion. The study findings demonstrate the positive impact of CDSS on several parameters that determine the quality and organization of medical care. The CDSS can be used to improve clinical and managerial decisions.
- 28 November 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (6) , 625-636
Open AccessThe impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)
Aim. To assess the effectiveness of clinical decision support system (CDSS) implementation strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients hospitalized for acute cardiovascular events (CVEs), in patients with coronary artery disease (CAD) or dyslipidemia.Material and methods. A non-interventional, retrospective, multicentre study assessing the impact of a CDSS with automatic electronic medical record (EMR) data processing on adherence to guidelines in patients at risk of cardiovascular diseases (SuccESS) was performed. The study included two cohorts of patients from healthcare facilities in three regions of Russia. The main cohort consisted of patients hospitalized for acute CVEs, with 12,227 patients included in the first follow-up period and 11,364 patients included in the second follow-up period. The additional cohort consisted of patients with stable CAD or dyslipidemia, with 54 469 patients included in the first follow-up period and 94,616 patients included in the second follow-up period. The study assessed follow-up findings in real-world clinical practice before and after the CDSS was implemented (first and second follow-up periods, respectively). The median duration of follow-up in the main cohort was >158 days in the first follow-up period and >227 days in the second follow-up period.Results. In the second follow-up period the proportion of patients with available data on LDL-C control in the EMR increased from 12.3% to 18.8% (here and further — relative change: +52.3%, pConclusion. The study findings demonstrate the positive impact of CDSS on several parameters that determine the quality and organization of medical care. The CDSS can be used to improve clinical and managerial decisions.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 18 (4)
Conduction disturbances after transcatheter aortic valve implantation
Aortic stenosis (AS) is the most common valvular disease in developed countries. Transcatheter aortic valve implantation (TAVI) is an efficient and safe procedure in the treatment of severe aortic stenosis with low risk of procedural complications. Indeed, accumulation of surgical experience has significantly reduced the incidence of procedural complications. However, high incidence of postoperative disorders of atrioventricular (AV) conduction is still a serious problem. This issue becomes even more important considering expansion of indications for TAVI in younger patients. This review is devoted to modern data on AV conduction disorders after TAVI and approaches to reducing the incidence of these complications.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 18 (4)
Conduction disturbances after transcatheter aortic valve implantation
Aortic stenosis (AS) is the most common valvular disease in developed countries. Transcatheter aortic valve implantation (TAVI) is an efficient and safe procedure in the treatment of severe aortic stenosis with low risk of procedural complications. Indeed, accumulation of surgical experience has significantly reduced the incidence of procedural complications. However, high incidence of postoperative disorders of atrioventricular (AV) conduction is still a serious problem. This issue becomes even more important considering expansion of indications for TAVI in younger patients. This review is devoted to modern data on AV conduction disorders after TAVI and approaches to reducing the incidence of these complications.